Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs

Lignende værker

• Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
  af: Valentina L. Kouznetsova, et al.
  Udgivet: (2020-09-01)
• Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies
  af: Rajkumar Kulandaisamy, et al.
  Udgivet: (2022-05-01)
• Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease
  af: Kandeel, Mahmoud, et al.
  Udgivet: (2020)
• MERS‐CoV papain-like protease (PL(pro)): expression, purification, and spectroscopic/thermodynamic characterization
  af: Malik, Ajamaluddin, et al.
  Udgivet: (2017)
• Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
  af: Kandeel, Mahmoud, et al.
  Udgivet: (2020)